Showing 51 - 60 of 148
The LSE Companion to Health Policy covers a wide range of conceptual and practical issues from a number of different perspectives introducing the reader to, and summarising, the vast literature that analyses the complexities of health policy. The Companion also assesses the current state of the art.
Persistent link: https://www.econbiz.de/10011175275
Persistent link: https://www.econbiz.de/10002411022
Persistent link: https://www.econbiz.de/10004620864
Valuing health outcomes is a fundamental concern in health economics. This article considers a measure of health outcomes: the Quality Adjusted Life Year (QALY). The QALY has been used extensively for two main reasons: (1) it arguably values health outcomes in a more acceptable metric than money...
Persistent link: https://www.econbiz.de/10010861118
The last decade has shown a concerted effort in the UK to find ways of reducing coronary heart disease (CHD), culminating in the recent government target of a 30% reduction in the rates in people under the age of 65 years to be achieved between 1988 and 2000 by modification of the main risk...
Persistent link: https://www.econbiz.de/10005344434
From 2020 Personal, Social, Health and Economic Education will be compulsory in UK schools for adolescents, however less is known about how it can be taught in a an effective manner. We examine, through a randomised trial, the impact of an evidenced based health related quality of life (HRQoL)...
Persistent link: https://www.econbiz.de/10012059169
A number of non-parametric estimators have been proposed to calculate average medical care costs in the presence of censoring. This paper assesses their performance both in terms of bias and efficiency under extreme conditions using a medical dataset which exhibits heavy censoring. The...
Persistent link: https://www.econbiz.de/10009439513
Pharmacoeconomic analyses have become useful and essential tools for health care decision makers who increasingly require such analyses prior to placing a drug on a national, regional or hospital formulary. Previous health economic models of non-steroidal anti-inflammatory drugs (NSAIDs) have...
Persistent link: https://www.econbiz.de/10009439514
Hospitals can be reimbursed for their costs in many ways. Several authors have investigated the effects of these reimbursement rules on physician incentives and, therefore, on the quantity of services provided to patients. A form of (linear) cost-sharing tends to emerge as the socially efficient...
Persistent link: https://www.econbiz.de/10009439515
A simulation model was constructed to assess the relative costs and cost-effectiveness of different screening and vaccination strategies for dealing with hospital incidents of varicella exposure, compared with current policies, using data from published sources and a hospital survey. The mean...
Persistent link: https://www.econbiz.de/10009439527